SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jian-ning Jiang, Zhan-lian Huang, Li-xia He, Yue-hua Huang, Ming-hua Su, Rong Xie, Yan-xiu Liang, Wu-dao Fu, Xiao-hong Huang, Wen-wen Guo, Shao-hua Zhong, Zhi-hong Liu, Shi-hua Li, Tuo-fu Zhu, Zhi-liang Gao, Residual Amount of HBV DNA in Serum is Related to Relapse in Chronic Hepatitis B Patients After Cessation of Nucleos(t)ide Analogs, Journal of Clinical Gastroenterology, 2015, 49, 4, 323

    CrossRef

  2. 2
    Da-biao Chen, You-ming Chen, Jing Liu, Dong-ying Xie, Cui-rong Lu, Zhan-lian Huang, Rui-hua Zhu, Zhi-liang Gao, Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients, Journal of Clinical Virology, 2014, 59, 1, 50

    CrossRef

  3. 3
    D. He, S. Guo, P. Zhu, S. Tao, M. Li, H. Huang, J. Wang, Y. Wang, M. Ding, Long-term outcomes after nucleos(t)ide analogue discontinuation in HBeAg-positive chronic hepatitis B patients, Clinical Microbiology and Infection, 2014, 20, 10
  4. 4
    Hyung Sohn, Bo Min, Joon Song, Mun Seong, Sang Lee, Eun Jang, Cheol Shin, Young Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Lee, Jin-Wook Kim, Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs, BMC Infectious Diseases, 2014, 14, 1, 439

    CrossRef

  5. 5
    Rosa María Martín-Mateos, Víctor F. Moreira Vicente, Luis Téllez-Villajos, Concepción García-Sánchez, María Teresa Maroto-Castellanos, Francisco Javier García-Alonso, María Luisa Mateos-Lindemann, Agustín Albillos, Tratamiento de la hepatitis crónica B antígeno e positiva con antivirales orales: experiencia y resultados en la práctica clínica, Gastroenterología y Hepatología, 2014, 37, 5, 280

    CrossRef

  6. 6
    Hee Yeon Kim, Jong Young Choi, Chung-Hwa Park, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae, Seung Kew Yoon, Jin Mo Yang, Chang Don Lee, Young Sok Lee, Outcome after discontinuing antiviral agents during pregnancy in women infected with hepatitis B virus, Journal of Clinical Virology, 2013, 56, 4, 299

    CrossRef

  7. 7
    Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae, Seung Kew Yoon, Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?, Journal of Medical Virology, 2013, 85, 1
  8. You have free access to this content8
    Hong Ma, Jidong Jia, Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue, Liver International, 2013, 33,
  9. 9
    Minghao Ha, Guotong Zhang, Shu Diao, Mingfang Lin, Liping Sun, Huiyuan She, Chenbao Kuan, Lihui Shen, Chunhong Huang, Wenjuan Shen, Zhongming Huang, A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir, Archives of Virology, 2012, 157, 2, 285

    CrossRef

  10. 10
    Tram T. Tran, High Frequency of Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy, Journal of Clinical Gastroenterology, 2012, 46, 10, 807

    CrossRef

  11. 11
    Feng Liu, Lei Wang, Xiao Ying Li, You De Liu, Jing Bo Wang, Zhao Hua Zhang, Yao Zong Wang, Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients, Journal of Gastroenterology and Hepatology, 2011, 26, 3
  12. 12
    James Fung, Ching-Lung Lai, Man-Fung Yuen, To stop or not to stop: The quest for long-term viral suppression, Journal of Gastroenterology and Hepatology, 2011, 26, 3